Towa Pharmaceutical Co Stock Net Income
| TWAPFDelisted Stock | USD 16.83 0.00 0.00% |
As of the 17th of February 2026, Towa Pharmaceutical has the Risk Adjusted Performance of 0.0361, coefficient of variation of 2927.17, and Variance of 56.5. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Towa Pharmaceutical, as well as the relationship between them. Please validate Towa Pharmaceutical risk adjusted performance, standard deviation, as well as the relationship between the Standard Deviation and maximum drawdown to decide if Towa Pharmaceutical is priced more or less accurately, providing market reflects its prevalent price of 16.83 per share. Given that Towa Pharmaceutical has variance of 56.5, we advise you to double-check Towa Pharmaceutical Co's current market performance to make sure the company can sustain itself at a future point.
Towa Pharmaceutical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Towa Pharmaceutical's valuation are provided below:Towa Pharmaceutical Co does not presently have any fundamental trend indicators for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Towa |
Search Suggestions
| T | ATT Inc | Company |
| TVC | Tennessee Valley Authority | Company |
| TDF | Templeton Dragon Closed | Fund |
| TAN | Invesco Solar ETF | ETF |
| TNX | Cboe Interest Rate | Index |
| THC | THC | Cryptocurrency |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Towa Pharmaceutical Co reported net income of 16.95 B. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The net income for all United States stocks is significantly lower than that of the firm.
Towa Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Towa Pharmaceutical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Towa Pharmaceutical could also be used in its relative valuation, which is a method of valuing Towa Pharmaceutical by comparing valuation metrics of similar companies.Towa Pharmaceutical is currently under evaluation in net income category among its peers.
Towa Fundamentals
| Return On Equity | 14.4 | |||
| Return On Asset | 5.47 | |||
| Profit Margin | 10.43 % | |||
| Operating Margin | 13.20 % | |||
| Current Valuation | 56.49 B | |||
| Shares Outstanding | 49.21 M | |||
| Shares Owned By Insiders | 47.82 % | |||
| Shares Owned By Institutions | 16.46 % | |||
| Price To Earning | 8.48 X | |||
| Price To Book | 0.01 X | |||
| Price To Sales | 0.01 X | |||
| Revenue | 162.51 B | |||
| Gross Profit | 65.45 B | |||
| EBITDA | 31.73 B | |||
| Net Income | 16.95 B | |||
| Cash And Equivalents | 24.39 B | |||
| Cash Per Share | 495.57 X | |||
| Total Debt | 79.68 B | |||
| Debt To Equity | 0.63 % | |||
| Current Ratio | 2.49 X | |||
| Cash Flow From Operations | 20.79 B | |||
| Earnings Per Share | 2.87 X | |||
| Number Of Employees | 3.46 K | |||
| Beta | 0.24 | |||
| Market Capitalization | 1.26 B | |||
| Last Dividend Paid | 0.44 |
About Towa Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Towa Pharmaceutical Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Towa Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Towa Pharmaceutical Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Consideration for investing in Towa Pink Sheet
If you are still planning to invest in Towa Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Towa Pharmaceutical's history and understand the potential risks before investing.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |